MedPath

High Flow Nasal Cannula Oxygen During Sedation for Video-assisted Thoracoscopic Surgery

Phase 2
Conditions
Respiratory Failure
Chronic Obstructive Pulmonary Disease
Interventions
Combination Product: CONTROL
Combination Product: High flow nasal cannula
Registration Number
NCT04520568
Lead Sponsor
Alexandria University
Brief Summary

High-flow nasal cannula (HFNC) is a device that delivers10 to 70 L min-1 of heated, humidified 100% oxygen via nasal route. It provides positive airway pressure, decreases dyspnea, decreases the work of breathing, and improves comfort

Detailed Description

Beneficial effects of the HFNC system have been assessed based on 3 physiologic conditions: decreased dead space, a high concentration of inspiratory oxygen, and positive pressure in the oro-laryngeal cavity.Studies have shown that it improves oxygenation in various perioperative settings such as the apneic patients, patients with respiratory failure , and patients undergoing bronchoscopy

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • ASA physical status II and III,
  • undergoing VATS
Exclusion Criteria
  • refusal of patients
  • extrem of age

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
control groupCONTROLinduction of general anaesthesia will be done using 2 mg/kg propofol and 1 µg/kg fentanyl. Double lumen tube will be facilitated by cisatracurium 0.2 mg/kg. Anaesthesia will be maintained with isoflurane 0.8 %-1% in 100% oxygen and maintenance dose of cisatracurium 0.02 mg/kg when needed. At the end of surgery, residual neuromuscular paralysis will be antagonized with neostigmine 0.05 mg/kg and atropine 0.01 mg/kg.
HFNC groupHigh flow nasal cannulaFor HFNC group, F\&P AIRVOTM 2 will be adjusted to give the patients the oxygen flow at 50L/min and the FiO2 at 1.0.Then after three minutes of preoxygenation, sedation will be conducted by giving 25 µg fentanyl and a bolus of 1 mg/kg propofol followed by continuous infusion of propofol using a target-controlled infusion system (TCI pump TE371; Terumo Corporation, TokyoJapan).
Primary Outcome Measures
NameTimeMethod
arterial partial pressures of oxygentwo hours

an arterial blood sample will be taken after induction of anaesthesia then every 10 min till the end of the operation.

pH measurementtwo hours

an arterial blood sample will be taken after induction of anaesthesia then every 10 min till the end of the operation.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rehab Abd Elraof Abd Elaziz

🇪🇬

Alexandria, Egypt

© Copyright 2025. All Rights Reserved by MedPath